¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ New paradiagm of CKD MBD management : 2019-09-29±³À°ÀÏÀÚ : 2019-09-29
±³À°Àå¼Ò : ¼¿ï/ °í´ë±¸·Îº´¿ø »õ·Ò ±³À°°ü 1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
New paradiagm of CKD MBD management ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸
´ã´çÀÚ : ¾È½Å¿µ
¿¬¶ôó : 02-000-0000
À̸ÞÀÏ :
ahnshinyoung712@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ 3¸¸¿ø/ ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç 2¸¸¿øÇöÀåµî·Ï: Àü¹®ÀÇ 4¸¸¿ø/ ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-29 ´ë°´ç 08:30~08:55 Favor Polymers including sevelamer È«À¯¾Æ(Ä«Å縯ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 08:55~09:20 Favor Metals including lanthanum, calcium, & magnesium ÀÌÁöÀº(¿ø±¤´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 09:20~09:45 Favor rookies in Korea: Iron ÀÌ¿µ±â(ÇѸ²´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 09:45~10:10 Favor VDRA ±è⼺(Àü³²´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 10:10~10:35 Favor cinacalcet ÃÖ¹ü¼ø(Ä«Å縯ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 10:35~11:00 Favor parathyroidectomy °í°Áö(°í·Á´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 11:00~11:40 Management of Secondary hyperparathyroidism in Japan including new calcimimetics (evocalcet and etelcalcetide) Masafumi Fukagawa(Tokai University)
±³À°½Ã°£ 09-29 ´ë°´ç 12:00~12:25 Pathophysiology and Diagnosis of vascular calcification ¾È¿ø¼®(µ¿¾Æ´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 12:25~12:45 Treatment of vascular calcification ¿À±¹È¯(¼¿ï´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 12:45~13:05 Physical activity for prevention and amelioration of Osteoporosis °¼®(°í·Á´ëÀÇ´ë ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 09-29 ´ë°´ç 13:05~13:30 Osteoporosis management in CKD – Case Review ±Ç¿µÁÖ(°í·Á´ëÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 09-29 ´ë°´ç 13:30~13:50 FLS (Fracture Liaison Service) in CKD ÇÏ¿ëÂù(Áß¾Ó´ëÀÇ´ë Á¤Çü¿Ü°ú)